Drugs / synthetic nonapeptides
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00116597 | Nov 2002 → Jul 2007 | melanoma | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | synthetic nonapeptides | “Boosts were subsequently applied with corresponding synthetic nonapeptides and GM-CSF.” PMID 11874634 ↗ Mar 2002 |
| Modality | Peptide | “Corresponding soluble peptides were used to boost responses” PMID 14577912 ↗ Nov 2003 |
| Route | Other | “Intranodal booster immunizations with synthetic melanoma associated epitopes” NCT00116597 ↗ |